Burcon Nutrascience Corporation
BRCND
$2.60
$0.000.00%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 101.09% | 79.40% | -20.92% | 51.51% | -50.16% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 101.09% | 79.40% | -20.92% | 51.51% | -50.16% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -547.02% | -268.27% | -127.24% | -24.22% | -50.16% |
| SG&A Expenses | 1.17% | 15.04% | 12.68% | 2.96% | -6.86% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.83% | 9.80% | 10.37% | -2.20% | -10.66% |
| Operating Income | -6.39% | -7.94% | -11.96% | 4.24% | 8.75% |
| Income Before Tax | -7.60% | -9.68% | 61.50% | 68.44% | 70.97% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -7.60% | -10.55% | 61.40% | 68.36% | 70.91% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -7.60% | -10.55% | 61.40% | 68.36% | 70.91% |
| EBIT | -6.39% | -7.94% | -11.96% | 4.24% | 8.75% |
| EBITDA | -6.10% | -7.78% | -12.42% | 4.21% | 8.77% |
| EPS Basic | 15.11% | 6.38% | 67.92% | 72.89% | 73.93% |
| Normalized Basic EPS | 15.12% | -159.29% | 23.78% | 42.60% | 50.09% |
| EPS Diluted | 15.11% | 6.38% | 67.92% | 72.89% | 73.93% |
| Normalized Diluted EPS | 15.12% | -159.29% | 23.78% | 42.60% | 50.09% |
| Average Basic Shares Outstanding | 28.84% | 18.16% | 16.93% | 15.71% | 11.64% |
| Average Diluted Shares Outstanding | 28.84% | 18.16% | 16.93% | 15.71% | 11.64% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |